These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pseudomonic acid, a new antibiotic for topical therapy. Wuite J; Davies BI; Go MJ; Lambers JC; Jackson D; Mellows G; Tasker TC J Am Acad Dermatol; 1985 Jun; 12(6):1026-31. PubMed ID: 3924981 [TBL] [Abstract][Full Text] [Related]
5. Topical mupirocin in the treatment of bacterial skin infections. Rumsfield J; West DP; Aronson IK Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197 [TBL] [Abstract][Full Text] [Related]
6. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections. Odom RB Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071 [TBL] [Abstract][Full Text] [Related]
7. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis. Luber H; Amornsiripanitch S; Lucky AW Arch Dermatol; 1988 Jun; 124(6):853-4. PubMed ID: 3132108 [No Abstract] [Full Text] [Related]
8. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. Gilbert M J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567 [TBL] [Abstract][Full Text] [Related]
9. [Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections]. Colin M; Avon P Pharmatherapeutica; 1988; 5(3):198-203. PubMed ID: 3129741 [TBL] [Abstract][Full Text] [Related]
10. Clinical and bacteriological efficacy of mupirocin (Bactroban): a new topical antibiotic. Gould PW; Villiger JW N Z Med J; 1986 Jul; 99(805):516. PubMed ID: 3090486 [No Abstract] [Full Text] [Related]
11. A new topical antibacterial agent. Watt B Microbiol Sci; 1987 Nov; 4(11):336-7. PubMed ID: 3155275 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial. Bork K; Brauers J; Kresken M Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of topical mupirocin in moderately severe primary and secondary skin infections. Buchvald J J Int Med Res; 1988; 16(1):66-70. PubMed ID: 3127257 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of mupirocin (pseudomonic acid) in the treatment of pyoderma in children. Phillips LM; Yogev R; Esterly NB Pediatr Emerg Care; 1985 Dec; 1(4):180-3. PubMed ID: 3939498 [No Abstract] [Full Text] [Related]
15. Comparative double-blinded study between mupirocin and tetracycline ointments for treating skin infections. Wong KS; Lim KB; Tham SN; Ling ML; Tan T Singapore Med J; 1989 Aug; 30(4):380-3. PubMed ID: 2510312 [TBL] [Abstract][Full Text] [Related]
16. Nasal carriage of gentamicin and methicillin resistant Staphylococcus aureus treated with topical pseudomonic acid. Dacre JE; Emmerson AM; Jenner EA Lancet; 1983 Oct; 2(8357):1036. PubMed ID: 6138588 [No Abstract] [Full Text] [Related]
17. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Ward A; Campoli-Richards DM Drugs; 1986 Nov; 32(5):425-44. PubMed ID: 3098541 [TBL] [Abstract][Full Text] [Related]
18. Pseudomonic acid and control of methicillin-resistant staphylococci. Casewell MW; Hill RL Lancet; 1983 Dec; 2(8362):1312. PubMed ID: 6139659 [No Abstract] [Full Text] [Related]